Senior Scientific Officer, Leukemia Research, Prof Kristian Helin, ID:564

Salary: Commencement on the salary range is subject to comparable skills and experience. Future progression is based on annual performance review.

Duration of Contract: Fixed Term for 3 years

Hours per week: 35 hours per week (Full Time)

Closing Date: 2nd April 2023

Under the leadership of Professor Kristian Helin, we are seeking to appoint a Senior Scientific Officer to join our Epigenetics and Cancer Team led by Kristian Helin to develop and use pre-clinical models for leukaemia, and to identify and validate new targets for anti-cancer therapy.

Key Requirements

The successful candidate must have a PhD in Life Sciences (Biology, Genetics, Biochemistry, Molecular Biology) and proved experience of working in haematology.

Department/Directorate Information:

The Epigenetics and Cancer team, directed by Professor Kristian Helin, studies the role of chromatin-associated proteins (epigenetics) in the regulation of transcription, cell fate decisions and in cancer. The team is also using functional genetic screens to identify potential novel targets for the development of anti-cancer therapy. 

We encourage all applicants to access the job pack attached for more detailed information regarding this role. For further  information discussion regarding the role, you may  contact Kristian Helin at [email protected]. 

Why work for us?

As a member of staff, you'll have exclusive access to a range of staff benefits.

The ICR is committed to supporting overseas applicants applying for roles, please click here to find out further information.

The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here.